NICE issues Final Draft Guidance recommending Lynparza (Olaparib) with abiraterone for patients with untreated hormone-relapsed metastatic prostate cancer
Bayer and Advanced Accelerator Applications (A Novartis Company) sponsor charity Prostate Cancer Research’s new collaborative project supported by IQVIA and backed by over 3,000 patients that aims to unleash the potential of health data